Logo

Sequenom Inks Deal with MultiPlan to Include MaterniT21 Plus Test

Apr 19, 2012

NEW YORK (GenomeWeb News) – Sequenom today announced an expanded agreement with healthcare cost management firm MultiPlan to include the MaterniT21 Plus LDT test for fetal aneuploidies.

As a result of the deal, MultiPlan's network of 900,000 providers will have access to Sequenom's test for trisomy 21, 18, and 13. The test was launched in October.

One of Sequenom's goals for 2012 is to sign two major national insurers as well as smaller payors in order to drive up adoption of the test. Earlier this week, the company increased its estimates for the number of billed MaterniT21 tests to 40,000 in 2012, up from a previous forecast of 25,000.

Filed under

Molecular Diagnostics
Reimbursement News
Disease Research
Clinical Sequencing
Sequencing
Diagnostics
aneuploidy
trisomy 21
genetic testing
Laboratory Corporation of America
Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.